Patients with terminal breast cancer could live for up to FIVE MONTHS longer by taking a cocktail of three drugs,
Continue reading »
Giving common antibiotic before radiation may help body fight cancer
The antibiotic vancomycin alters the gut microbiome in a way that can help prime the immune system to more effectively
Continue reading »Progress slow against pancreatic cancer
Pancreatic cancer is the third deadliest form of the disease after lung cancer and colorectal cancer. There is no effective
Continue reading »Taking aspirin three times a week may cut the risk of dying of cancer
Taking aspirin three times a week may cut the risk of dying of cancer by fighting inflammation, study suggests NIH
Continue reading »Study shows link between precipitation, climate zone and invasive cancer rates in the US
In a new study, researchers provide conclusive evidence of a statistical relationship between the incidence rates of invasive cancer in
Continue reading »Prostate cancer ‘super responders’ live for two years on immunotherapy
Some men with advanced prostate cancer who have exhausted all other treatment options could live for two years or more
Continue reading »A novel pathway to target colorectal cancer
While the emergence of precision medicine and immunotherapy has greatly improved outcomes for patients with colorectal cancer, new approaches are
Continue reading »Treatment beneficial for nonagenarians with lung cancer
(HealthDay)—Receiving treatment is associated with better survival for nonagenarians with non-small cell lung cancer (NSCLC), with the greatest survival benefit
Continue reading »Cell death or cancer growth: A question of cohesion
Activation of CD95, a receptor found on all cancer cells, triggers programmed cell death—or does the opposite, namely stimulates cancer
Continue reading »New screening method identifies inhibitors of cancer cell metabolism
A new screening system developed by scientists at the UCLA Jonsson Comprehensive Cancer Center leverages redundancy in an important component
Continue reading »